Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Aimmune Therap
(NQ:
AIMT
)
34.49
USD
UNCHANGED
Last Price
Updated: 7:11 PM EDT, Oct 12, 2020
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Stories about Aimmune Therap
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Aimmune Therapeutics Larger Than S&P 500 Component Under Armour
September 25, 2020
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component Aimmune Therapeutics Inc (AIMT) was identified as having a larger market cap than the smaller end of the...
Tags
Stocks
From
Market News Video
Why Aimmune Therapeutics Stock Jumped by 159% in August
September 08, 2020
Nestle is buying the small-cap biotech, and it's paying a high premium.
Tags
Market News
AIMT
NSRGY
From
Motley Fool
2 Mid-Cap Healthcare Stocks to Buy Now
September 05, 2020
These drugmakers are in the sweet spot to provide market-beating returns.
Tags
Market News
CDNA
AGIO
From
Motley Fool
Benzinga's Top Upgrades, Downgrades For September 1, 2020
September 01, 2020
Upgrades For Qualcomm Inc (NASDAQ: QCOM), Wells Fargo upgraded the previous rating of Underweight to the current rating ...
Tags
Benzinga
Penny Stocks
MSI
From
Benzinga
Surge in megadeals points to M&A recovery as tech sector dominates
September 01, 2020
Nine deals worth $5 billion or more were announced in August, the biggest tally for that month since 1999.
Tags
UK:AVV
Energy
M&A
From
MarketWatch
10 Biggest Price Target Changes For Tuesday
September 01, 2020
Goldman Sachs raised the price target for Zoom Video Communications Inc (NASDAQ: ZM) from $187 to $402. Zoom Video shares rose 30% ...
Tags
CHUY
ZM
AIMT
From
Benzinga
60 Biggest Movers From Yesterday
September 01, 2020
Gainers Aimmune Therapeutics, Inc (NASDAQ: AIMT) shares jumped 171.6% to close at $34.22 on Monday after Nestle SA agreed to ...
Tags
UONE
SHLO
IGC
From
Benzinga
Stock Markets Celebrate a Strong August; Nestle's Hungry for Aimmune as Utz Feeds IPO Investors
August 31, 2020
It was a mixed day for the markets.
Tags
CCH
Market News
^DJI
From
Motley Fool
Notable Monday Option Activity: RST, AIMT, ZM
August 31, 2020
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Rosetta Stone Inc (RST), where a total volume of 46,468 contracts has been traded...
Tags
Stocks
From
Market News Video
Mid-Afternoon Market Update: Nasdaq Rises Over 100 Points; Regis Shares Drop After Q4 Results
August 31, 2020
Toward the end of trading Monday, the Dow traded down 0.72% to 28446.24 while the NASDAQ rose 1% to 11,812.92. The S&P also rose, ...
Tags
News
Global
Benzinga
From
Benzinga
Aimmune Therapeutics soars 172% after Nestle agrees to acquire the peanut allergy treatment company for $2.6 billion (AIMT)
August 31, 2020
From
Business Insider
European stocks fall on the last day of August trading
August 31, 2020
European stocks struggled on Monday, in a month that’s set to deliver a 3.3% gain for the region’s main index.
Tags
Pharmaceuticals
DX:DAX
CH:NESN
From
MarketWatch
50 Stocks Moving In Monday's Mid-Day Session
August 31, 2020
Gainers Aimmune Therapeutics, Inc (NASDAQ: AIMT) shares climbed 171.5% to $34.21 after Nestle SA agreed to acquire the company at ...
Tags
Benzinga
BIGC
Penny Stocks
From
Benzinga
50 Stocks Moving In Monday's Mid-Day Session
August 31, 2020
Gainers Aimmune Therapeutics, Inc (NASDAQ: AIMT) shares climbed 171.5% to $34.21 after Nestle SA agreed to acquire the company at ...
Tags
CHFS
News
Penny Stocks
From
Benzinga
Monday's ETF Movers: XBI, EEMA
August 31, 2020
In trading on Monday, the SPDR— S&P— Biotech ETF is outperforming other ETFs, up about 2.6% on the day. Components of that ETF showing particular strength include shares of Aimmune Therapeutics, up...
Tags
ETFs
From
ETF Channel
Dow Jones Tumbles, Nasdaq Hits New High As Stocks Head For Big August Gains
August 31, 2020
Stocks were mixed on the last trading day of August as the Nasdaq hit a new high but the Dow Jones Industrial Average fell over 200 points.
From
Investor's Business Daily
Mid-Day Market Update: Akcea Therapeutics Jumps Following Acquisition News; Acasti Pharma Shares Plummet
August 31, 2020
Midway through trading Monday, the Dow traded down 0.94% to 28385.03 while the NASDAQ rose 0.23% to 11722.14. The S&P also fell, ...
Tags
AKCA
RGS
Earnings
From
Benzinga
Mid-Morning Market Update: Markets Mostly Lower; Nestlé To Acquire Aimmune Therapeutics
August 31, 2020
Following the market opening Monday, the Dow traded down 0.60% to 28483.09 while the NASDAQ rose 0.26% to 11,725.76. The S&P also ...
Tags
Earnings
AIMT
Eurozone
From
Benzinga
Nestle To Buy Peanut Allergy Treatment Maker Aimmune For $2.6 Billion
August 31, 2020
Swiss food giant Nestle early Monday announced an agreement to buy Aimmune Therapeutics, the maker of the only approved drug to treat peanut allergies, for $2.6 billion. AIMT stock soared.
From
Investor's Business Daily
Nestle Acquires Aimmune For $34.50 Per Share In Cash Or $2.6B
August 31, 2020
Aimmune Therapeutics announced that it has entered into a definitive agreement for Societes des Produits Nestle to acquire Aimmune for $34.50 per share in an all-cash transaction, implying a...
Tags
Stocks / Equities
Pharma/Biotech
Consumer Goods
From
Blogs - TalkMarkets
ROCE Insights For Aimmune Therapeutics
August 31, 2020
During Q2, Aimmune Therapeutics (NASDAQ: AIMT) earnings decreased 22.62%, resulting in a loss of $65.99 million. In Q1, Aimmune ...
Tags
Earnings
Benzinga
General
From
Benzinga
Why Aimmune Therapeutics Stock Is Soaring Today
August 31, 2020
Nestle is gobbling up the peanut allergy drugmaker Aimmune Therapeutics for a cool $2.6 billion.
Tags
Market News
AIMT
NSRGY
From
Motley Fool
An ‘extreme’ August on the stock market might be telling us something about the November election
August 31, 2020
It has been a pretty bullish August for the stock market. That tends to work well in an incumbent U.S. President’s favor, but our call of the day says a twist could lie ahead.
Tags
Health/Care
QQQ
M&A
From
MarketWatch
38 Stocks Moving in Monday's Pre-Market Session
August 31, 2020
Gainers Aimmune Therapeutics, Inc (NASDAQ: AIMT) shares rose 169.8% to $34.00 in pre-market trading after Nestle SA agreed to ...
Tags
GSM
NTEC
Top Gainers
From
Benzinga
A Peek Into The Markets: US Stock Futures Gain Ahead Of Zoom Earnings
August 31, 2020
Pre-open movers U.S. stock futures traded higher in early pre-market trade. Stocks recorded gains during the previous session, with ...
Tags
Futures
SCSC
CTLT
From
Benzinga
Aimmune Shares Surge 170% As Nestle Set To Acquire Company At $2.6B Enterprise Value
August 31, 2020
Nestle S.A. (OTC: NSRGY) subsidiaryNestle Health Sciences (NHSc) is aquiringbiopharma companyAimmune Therapeutics, ...
Tags
AIMT
Markets
NSRGY
From
Benzinga
Analysts Expect 10% Upside For The Holdings of ESML
August 14, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Could This Small-Cap Biotech Stock Make You Rich?
August 11, 2020
Thanks to bad news for its competitor, this company behind the first FDA-approved peanut allergy treatment could be ripe for a rebound.
Tags
Market News
AIMT
DBVT
From
Motley Fool
Is Aimmune Therapeutics a Buy?
August 06, 2020
Is this battered biotech stock now a good deal for investors?
Tags
Market News
AIMT
From
Motley Fool
Why Shares of Aimmune Are Trading Higher While DBV Plunges
August 04, 2020
Aimmune Therapeutics Inc (NASDAQ: AIMT) shares, which recovered Monday following an earnings-induced sell-off Friday, are adding to the ...
Tags
Market News
Top Stories
FDA
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.